{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:17:27Z","timestamp":1792275447858,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00347-023-01945-y","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T08:02:39Z","timestamp":1697616159000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnosis and treatment of malignant eyelid tumors","Diagnose und Therapie der malignen Lidtumoren. Englische Version"],"prefix":"10.1007","volume":"121","author":[{"given":"S.","family":"Gniesmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schiemenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Heindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Varde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kakkassery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"1945_CR1","volume-title":"Dermatoscopy","author":"W Adamski","year":"2022","unstructured":"Adamski\u00a0W, Adamska\u00a0K (2022) Pigmented lesions of the eyelid margin. In: Pietkiewicz\u00a0P (ed) Dermatoscopy. IntechOpen, London"},{"issue":"1","key":"1945_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","volume":"15","author":"F Bath-Hextall","year":"2014","unstructured":"Bath-Hextall\u00a0F, Ozolins\u00a0M, Armstrong\u00a0SJ, Colver\u00a0GB, Perkins\u00a0W, Miller\u00a0PSJ, Williams\u00a0HC (2014) Surgical excision versus imiquimod 5\u202f% cream for nodular and superficial basal-cell carcinoma (SINS): a\u00a0multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 15(1):96\u2013105. https:\/\/doi.org\/10.1016\/S1470-2045(13)70530-8","journal-title":"Lancet Oncol"},{"key":"1945_CR3","volume-title":"S2k \u2013 Leitlinie \u2013 Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut)","author":"JC Becker","year":"2018","unstructured":"Becker\u00a0JC, Eigentler\u00a0T, Frerich\u00a0B, Gambichler\u00a0T, Grabbe\u00a0S, H\u00f6ller\u00a0U, Klumpp\u00a0B, Loquai\u00a0C, Krause-Bergmann\u00a0A, M\u00fcller-Richter\u00a0U, Pf\u00f6hler\u00a0C, Schneider-Burrus\u00a0S, Stang\u00a0A, Terheyden\u00a0P, Ugurel\u00a0S, Veith\u00a0J, Mauch\u00a0C (2018) S2k \u2013 Leitlinie \u2013 Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) (Update 2018)"},{"issue":"2","key":"1945_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12105-016-0707-8","volume":"10","author":"JO Black","year":"2016","unstructured":"Black\u00a0JO (2016) Xeroderma Pigmentosum. Head Neck Pathol 10(2):139\u2013144. https:\/\/doi.org\/10.1007\/s12105-016-0707-8","journal-title":"Head Neck Pathol"},{"issue":"1","key":"1945_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000511215","volume":"7","author":"P Brunetti","year":"2021","unstructured":"Brunetti\u00a0P, Margo\u00a0CE, French\u00a0DD (2021) Incidence of cutaneous melanoma of eyelid analysis of the surveillance, epidemiology, and end results database. Ocul Oncol Pathol 7(1):66\u201369. https:\/\/doi.org\/10.1159\/000511215","journal-title":"Ocul Oncol Pathol"},{"issue":"5","key":"1945_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10792-018-0925-z","volume":"39","author":"MV Cicinelli","year":"2019","unstructured":"Cicinelli\u00a0MV, Kaliki\u00a0S (2019) Ocular sebaceous gland carcinoma: an update of the literature. Int Ophthalmol 39(5):1187\u20131197. https:\/\/doi.org\/10.1007\/s10792-018-0925-z","journal-title":"Int Ophthalmol"},{"key":"1945_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.77","volume-title":"Stellungnahme zur Nutzenbewertung gem\u00e4\u00df \u00a7 35a SGB V Avelumab","author":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie","year":"2020","unstructured":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie (2020) Stellungnahme zur Nutzenbewertung gem\u00e4\u00df \u00a7 35a SGB V Avelumab https:\/\/doi.org\/10.1038\/nrdp.2017.77"},{"key":"1945_CR8","volume-title":"Stellungnahme zur Nutzenbewertung des G-BA von Arzneimitteln gem\u00e4\u00df \u00a7 35a SGB V Cemiplimab (neues Anwendungsgebiet, Basalzellkarzinom, fortgeschritten oder metastasiert, nach Vortherapie)","author":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie","year":"2021","unstructured":"Deutsche Gesellschaft f\u00fcr H\u00e4matologie und medizinische Onkologie (2021) Stellungnahme zur Nutzenbewertung des G\u2011BA von Arzneimitteln gem\u00e4\u00df \u00a7 35a SGB V Cemiplimab (neues Anwendungsgebiet, Basalzellkarzinom, fortgeschritten oder metastasiert, nach Vortherapie)"},{"issue":"1","key":"1945_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-018-0357-3","volume":"6","author":"E Domingo-Musibay","year":"2018","unstructured":"Domingo-Musibay\u00a0E, Murugan\u00a0P, Giubellino\u00a0A, Sharma\u00a0S, Steinberger\u00a0D, Yuan\u00a0J, Hunt\u00a0MA, Lou\u00a0E, Miller\u00a0JS (2018) Near complete response to pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma. J\u00a0Immunother Cancer 6(1):58. https:\/\/doi.org\/10.1186\/s40425-018-0357-3","journal-title":"J Immunother Cancer"},{"issue":"5","key":"1945_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/IOP.0000000000000554","volume":"32","author":"MD Elia","year":"2016","unstructured":"Elia\u00a0MD, Lally\u00a0SE, Hanlon\u00a0AM, Choi\u00a0JN, Servat\u00a0JJ, Shields\u00a0JA, Shields\u00a0CL, Levin\u00a0F (2016) Periocular melanoma in situ treated with Imiquimod. Ophthalmic Plast Reconstr Surg 32(5):371\u2013373. https:\/\/doi.org\/10.1097\/IOP.0000000000000554","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"1945_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4081\/oncol.2020.420","volume":"14","author":"A Furdova","year":"2020","unstructured":"Furdova\u00a0A, Kapitanova\u00a0K, Kollarova\u00a0A, Sekac\u00a0J (2020) Periocular basal cell carcinoma\u2014clinical perspectives. Oncol Rev 14(1):420. https:\/\/doi.org\/10.4081\/oncol.2020.420","journal-title":"Oncol Rev"},{"key":"1945_CR12","volume-title":"Muir-Torre syndrome","author":"JT Gay","year":"2022","unstructured":"Gay\u00a0JT, Troxell\u00a0T, Gross\u00a0GP (2022) Muir-Torre syndrome. StatPearls, Treasure Island (FL)"},{"issue":"5","key":"1945_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","volume":"50","author":"J Geisse","year":"2004","unstructured":"Geisse\u00a0J, Caro\u00a0I, Lindholm\u00a0J, Golitz\u00a0L, Stampone\u00a0P, Owens\u00a0M (2004) Imiquimod 5\u202f% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J\u00a0Am Acad Dermatol 50(5):722\u2013733. https:\/\/doi.org\/10.1016\/j.jaad.2003.11.066","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1945_CR14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00262-020-02832-0","volume":"70","author":"V Glutsch","year":"2021","unstructured":"Glutsch\u00a0V, Kneitz\u00a0H, Gesierich\u00a0A, Goebeler\u00a0M, Haferkamp\u00a0S, Becker\u00a0JC, Ugurel\u00a0S, Schilling\u00a0B (2021) Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma. Cancer Immunol Immunother 70(7):2087\u20132093. https:\/\/doi.org\/10.1007\/s00262-020-02832-0","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1945_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0009-9260(86)80161-1","volume":"37","author":"VL Hall","year":"1986","unstructured":"Hall\u00a0VL, Leppard\u00a0BJ, McGill\u00a0J, Kesseler\u00a0ME, White\u00a0JE, Goodwin\u00a0P (1986) Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 37(1):33\u201334. https:\/\/doi.org\/10.1016\/s0009-9260(86)80161-1","journal-title":"Clin Radiol"},{"issue":"8","key":"1945_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bjps.2013.04.032","volume":"66","author":"V Harish","year":"2013","unstructured":"Harish\u00a0V, Bond\u00a0JS, Scolyer\u00a0RA, Haydu\u00a0LE, Saw\u00a0RPM, Quinn\u00a0MJ, Benger\u00a0RS, Uren\u00a0RF, Stretch\u00a0JR, Shannon\u00a0KF, Thompson\u00a0JF (2013) Margins of excision and prognostic factors for cutaneous eyelid melanomas. J\u00a0Plast Reconstr Aesthet Surg 66(8):1066\u20131073. https:\/\/doi.org\/10.1016\/j.bjps.2013.04.032","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"11","key":"1945_CR17","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","volume":"23","author":"KL Harms","year":"2016","unstructured":"Harms\u00a0KL, Healy\u00a0MA, Nghiem\u00a0P, Sober\u00a0AJ, Johnson\u00a0TM, Bichakjian\u00a0CK, Wong\u00a0SL (2016) Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol 23(11):3564\u20133571. https:\/\/doi.org\/10.1245\/s10434-016-5266-4","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1945_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","volume":"33","author":"RI Hartman","year":"2019","unstructured":"Hartman\u00a0RI, Lin\u00a0JY (2019) Cutaneous melanoma\u2014a review in detection, staging, and management. Hematol Oncol Clin North Am 33(1):25\u201338. https:\/\/doi.org\/10.1016\/j.hoc.2018.09.005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"1945_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaophthalmol.2013.6077","volume":"132","author":"HM Herbert","year":"2014","unstructured":"Herbert\u00a0HM, Sun\u00a0MT, Selva\u00a0D, Fernando\u00a0B, Saleh\u00a0GM, Beaconsfield\u00a0M, Collin\u00a0R, Uddin\u00a0J, Meligonis\u00a0G, Leatherbarrow\u00a0B, Ataullah\u00a0S, Irion\u00a0L, McLean\u00a0CJ, Huilgol\u00a0SC, Davis\u00a0G, Sullivan\u00a0TJ (2014) Merkel cell carcinoma of the eyelid: management and prognosis. JAMA Ophthalmol 132(2):197\u2013204. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.6077","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1945_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00347-016-0355-0","volume":"114","author":"R Hoerster","year":"2017","unstructured":"Hoerster\u00a0R, Schlaak\u00a0M, Koch\u00a0KR, Ortmann\u00a0M, Mauch\u00a0C, Heindl\u00a0LM (2017) Merkel-Zell-Karzinom des Augenlids \u2013 eine h\u00e4ufig verkannte Diagnose : Klinische Aspekte und Behandlungsmethoden. Ophthalmologe 114(2):134\u2013139. https:\/\/doi.org\/10.1007\/s00347-016-0355-0","journal-title":"Ophthalmologe"},{"issue":"9","key":"1945_CR21","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/bjc.1998.666","volume":"78","author":"S Holmes","year":"1998","unstructured":"Holmes\u00a0S (1998) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a\u00a0randomized study. Br J Cancer 78(9):1257. https:\/\/doi.org\/10.1038\/bjc.1998.666","journal-title":"Br J Cancer"},{"key":"1945_CR22","volume-title":"Basalzellkarzinom-der-Haut","author":"B Lang","year":"2018","unstructured":"Lang\u00a0B et al (2018) Basalzellkarzinom-der-Haut"},{"key":"1945_CR23","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2018) S3 Leitlinie Aktinische Keratose und Plattenepithelkarzinom der Haut, Langversion 0.1 (Konsultationsfassung). https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/aktinische-keratosen-und- plattenepithelkarzinom-der-haut\/. Zugegriffen: 7. Juni 2022 (AWMF Registernummer: 032\/022OL)"},{"issue":"2","key":"1945_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1442-9071.2006.01411.x","volume":"35","author":"V Limawararut","year":"2007","unstructured":"Limawararut\u00a0V, Leibovitch\u00a0I, Sullivan\u00a0T, Selva\u00a0D (2007) Periocular squamous cell carcinoma. Clin Experiment Ophthalmol 35(2):174\u2013185. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01411.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"1945_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.survophthal.2018.12.002","volume":"64","author":"N Mancera","year":"2019","unstructured":"Mancera\u00a0N, Smalley\u00a0KSM, Margo\u00a0CE (2019) Melanoma of the eyelid and periocular skin: histopathologic classification and molecular pathology. Surv Ophthalmol 64(3):272\u2013288. https:\/\/doi.org\/10.1016\/j.survophthal.2018.12.002","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"1945_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/cancers6021128","volume":"6","author":"H Merritt","year":"2014","unstructured":"Merritt\u00a0H, Sniegowski\u00a0MC, Esmaeli\u00a0B (2014) Merkel cell carcinoma of the eyelid and periocular region. Cancers (Basel) 6(2):1128\u20131137. https:\/\/doi.org\/10.3390\/cancers6021128","journal-title":"Cancers (Basel)"},{"issue":"10","key":"1945_CR27","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.disamonth.2020.101046","volume":"66","author":"JM Moran","year":"2020","unstructured":"Moran\u00a0JM, Phelps\u00a0PO (2020) Periocular skin cancer: diagnosis and management. Dis Mon 66(10):101046. https:\/\/doi.org\/10.1016\/j.disamonth.2020.101046","journal-title":"Dis Mon"},{"key":"1945_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14307_g","author":"L Onkologie","year":"2020","unstructured":"Onkologie\u00a0L (2020) S3 \u2013 Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms. J\u00a0Dtsch Dermatol Ges. https:\/\/doi.org\/10.1111\/ddg.14307_g","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"1945_CR29","doi-asserted-by":"publisher","first-page":"e699","DOI":"10.1016\/S1470-2045(19)30673-4","volume":"20","author":"JL Owen","year":"2019","unstructured":"Owen\u00a0JL, Kibbi\u00a0N, Worley\u00a0B et al (2019) Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 20(12):e699\u2013e714. https:\/\/doi.org\/10.1016\/S1470-2045(19)30673-4","journal-title":"Lancet Oncol"},{"issue":"3","key":"1945_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ad.2017.07.018","volume":"109","author":"I Palacios-\u00c1lvarez","year":"2018","unstructured":"Palacios-\u00c1lvarez\u00a0I, Gonz\u00e1lez-Sarmiento\u00a0R, Fern\u00e1ndez-L\u00f3pez\u00a0E (2018) S\u00edndrome de Gorlin. Actas Dermosifiliogr 109(3):207\u2013217. https:\/\/doi.org\/10.1016\/j.ad.2017.07.018","journal-title":"Actas Dermosifiliogr"},{"issue":"9","key":"1945_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0161-6420(01)00701-1","volume":"108","author":"GB Peters","year":"2001","unstructured":"Peters\u00a0GB, Meyer\u00a0DR, Shields\u00a0JA, Custer\u00a0PL, Rubin\u00a0PA, Wojno\u00a0TH, Bersani\u00a0TA, Tanenbaum\u00a0M (2001) Management and prognosis of merkel cell carcinoma of the eyelid. Ophthalmology 108(9):1575\u20131579. https:\/\/doi.org\/10.1016\/S0161-6420(01)00701-1","journal-title":"Ophthalmology"},{"issue":"2","key":"1945_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/bjophthalmol-2015-308261","volume":"101","author":"GM Saleh","year":"2017","unstructured":"Saleh\u00a0GM, Desai\u00a0P, Collin\u00a0JRO, Ives\u00a0A, Jones\u00a0T, Hussain\u00a0B (2017) Incidence of eyelid basal cell carcinoma in England: 2000\u20132010. Br J Ophthalmol 101(2):209\u2013212. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-308261","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1945_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jfo.2020.07.019","volume":"44","author":"SY Sendul","year":"2021","unstructured":"Sendul\u00a0SY, Akpolat\u00a0C, Yilmaz\u00a0Z, Eryilmaz\u00a0OT, Guven\u00a0D, Kabukcuoglu\u00a0F (2021) Clinical and pathological diagnosis and comparison of benign and malignant eyelid tumors. J\u00a0Fr Ophtalmol 44(4):537\u2013543. https:\/\/doi.org\/10.1016\/j.jfo.2020.07.019","journal-title":"J Fr Ophtalmol"},{"key":"1945_CR34","doi-asserted-by":"publisher","first-page":"4858636","DOI":"10.1155\/2020\/4858636","volume":"2020","author":"Y Shan","year":"2020","unstructured":"Shan\u00a0Y, Xu\u00a0Y, Lu\u00a0Y, Chen\u00a0M, Cao\u00a0J, Wang\u00a0Y, Lin\u00a0X, Ye\u00a0J (2020) Epidemiology and survival outcomes for eyelid primary malignant melanoma: an analysis of 1397 cases in the SEER database. J\u00a0Ophthalmol 2020:4858636. https:\/\/doi.org\/10.1155\/2020\/4858636","journal-title":"J Ophthalmol"},{"key":"1945_CR35","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2147\/OTT.S130371","volume":"10","author":"Y Shi","year":"2017","unstructured":"Shi\u00a0Y, Jia\u00a0R, Fan\u00a0X (2017) Ocular basal cell carcinoma: a\u00a0brief literature review of clinical diagnosis and treatment. Onco Targets Ther 10:2483\u20132489. https:\/\/doi.org\/10.2147\/OTT.S130371","journal-title":"Onco Targets Ther"},{"issue":"6","key":"1945_CR36","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","volume":"22","author":"AJ Stratigos","year":"2021","unstructured":"Stratigos\u00a0AJ, Sekulic\u00a0A, Peris\u00a0K et al (2021) Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet Oncol 22(6):848\u2013857. https:\/\/doi.org\/10.1016\/S1470-2045(21)00126-1","journal-title":"Lancet Oncol"},{"issue":"4","key":"1945_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/IIO.0b013e3181b7ecd1","volume":"49","author":"TJ Sullivan","year":"2009","unstructured":"Sullivan\u00a0TJ (2009) Squamous cell carcinoma of eyelid, periocular, and periorbital skin. Int Ophthalmol Clin 49(4):17\u201324. https:\/\/doi.org\/10.1097\/IIO.0b013e3181b7ecd1","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"1945_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-4725.2007.34115.x","volume":"34","author":"MK Thosani","year":"2008","unstructured":"Thosani\u00a0MK, Schneck\u00a0G, Jones\u00a0EC (2008) Periocular squamous cell carcinoma. Dermatol Surg 34(5):585\u2013599. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.34115.x","journal-title":"Dermatol Surg"},{"issue":"6","key":"1945_CR39","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jaad.2016.07.046","volume":"75","author":"R Tripathi","year":"2016","unstructured":"Tripathi\u00a0R, Chen\u00a0Z, Li\u00a0L, Bordeaux\u00a0JS (2016) Incidence and survival of sebaceous carcinoma in the United States. J\u00a0Am Acad Dermatol 75(6):1210\u20131215. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.046","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1945_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/0974-620X.71885","volume":"3","author":"UK Wali","year":"2010","unstructured":"Wali\u00a0UK, Al-Mujaini\u00a0A (2010) Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol 3(3):117\u2013121. https:\/\/doi.org\/10.4103\/0974-620X.71885","journal-title":"Oman J Ophthalmol"},{"issue":"12","key":"1945_CR41","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00347-016-0387-5","volume":"113","author":"M Weiling","year":"2016","unstructured":"Weiling\u00a0M, Bergua\u00a0A, Kruse\u00a0FE, Holbach\u00a0L (2016) Therapie bei malignen Lidtumoren. Ophthalmologe 113(12):1095\u20131108. https:\/\/doi.org\/10.1007\/s00347-016-0387-5","journal-title":"Ophthalmologe"},{"issue":"7","key":"1945_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ceo.12298","volume":"42","author":"A Wu","year":"2014","unstructured":"Wu\u00a0A, Sun\u00a0MT, Huilgol\u00a0SC, Madge\u00a0S, Selva\u00a0D (2014) Histological subtypes of periocular basal cell carcinoma. Clin Experiment Ophthalmol 42(7):603\u2013607. https:\/\/doi.org\/10.1111\/ceo.12298","journal-title":"Clin Experiment Ophthalmol"},{"issue":"5","key":"1945_CR43","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jamaophthalmol.2019.0238","volume":"137","author":"S Xu","year":"2019","unstructured":"Xu\u00a0S, Sagiv\u00a0O, Rubin\u00a0ML, Sa\u00a0H\u2011S, Tetzlaff\u00a0MT, Nagarajan\u00a0P, Ning\u00a0J, Esmaeli\u00a0B (2019) Validation study of the AJCC cancer staging manual, eighth edition, staging system for eyelid and periocular squamous cell carcinoma. JAMA Ophthalmol 137(5):537\u2013542. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.0238","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"1945_CR44","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jaad.2018.12.053","volume":"80","author":"C Zhou","year":"2019","unstructured":"Zhou\u00a0C, Wu\u00a0F, Chai\u00a0P, Shi\u00a0Y, Ye\u00a0J, Shi\u00a0X, Tan\u00a0J, Ding\u00a0Y, Luo\u00a0Y, Esmaeli\u00a0B, Jia\u00a0R, Fan\u00a0X (2019) Mohs micrographic surgery for eyelid sebaceous carcinoma: a multicenter cohort of 360\u00a0patients. J\u00a0Am Acad Dermatol 80(6):1608\u20131617.e1. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.053","journal-title":"J Am Acad Dermatol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01945-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01945-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T11:03:22Z","timestamp":1706871802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01945-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":44,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01945-y","relation":{"is-translation-of":[{"id-type":"doi","id":"10.1007\/s00347-023-01820-w","asserted-by":"subject"}]},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"21 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Gniesmer, S.R.\u00a0Sonntag, C.\u00a0Schiemenz, M.\u00a0Ranjbar, L.M.\u00a0Heindl, M.A.\u00a0Varde, S.\u00a0Emmert, S.\u00a0Grisanti, and V.\u00a0Kakkassery declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were conducted in accordance with the ethical standards indicated in each case. Written consent has been obtained from patients and\/or their legal representatives for images or other information within the manuscript by which patients can be identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}